Literature DB >> 16977547

Attention-deficit/hyperactivity disorder (ADHD) in the course of life.

Götz-Erik Trott.   

Abstract

ADHD is a pervasive disorder that extensively impairs the quality of life and that can lead to serious secondary problems. Contrary to the prior assumption long-term studies have demonstrated that the disorder is not limited to childhood and adolescence. Unfortunately appropriate criteria for adults with ADHD are not given in the ICD-10. The clinical experience indicates substantial difficulties of adults, whose ADHS is not diagnosed and treated. They often cause extensive costs for the welfare system. The evidence-based psychiatric treatment is highly effective and inexpensive.

Entities:  

Mesh:

Year:  2006        PMID: 16977547     DOI: 10.1007/s00406-006-1003-5

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  18 in total

1.  Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.

Authors:  Ronald C Kessler; Lenard A Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Stephen V Faraone; Laurence L Greenhill; Savina Jaeger; Kristina Secnik; Thomas Spencer; T Bedirhan Ustün; Alan M Zaslavsky
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

Review 2.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

Review 3.  Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review.

Authors:  Erik G Willcutt; Alysa E Doyle; Joel T Nigg; Stephen V Faraone; Bruce F Pennington
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

4.  A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.

Authors:  Thomas Spencer; Joseph Biederman; Timothy Wilens; Robert Doyle; Craig Surman; Jefferson Prince; Eric Mick; Megan Aleardi; Kathleen Herzig; Stephen Faraone
Journal:  Biol Psychiatry       Date:  2005-03-01       Impact factor: 13.382

Review 5.  Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?

Authors:  Joel T Nigg; Erik G Willcutt; Alysa E Doyle; Edmund J S Sonuga-Barke
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

6.  Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

Authors:  J J S Kooij; H Burger; A M Boonstra; P D Van der Linden; L E Kalma; J K Buitelaar
Journal:  Psychol Med       Date:  2004-08       Impact factor: 7.723

7.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

Authors:  M F Ward; P H Wender; F W Reimherr
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

8.  History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study.

Authors:  Andrea Fossati; Liliana Novella; Deborah Donati; Michela Donini; Cesare Maffei
Journal:  Compr Psychiatry       Date:  2002 Sep-Oct       Impact factor: 3.735

9.  Gender effects on attention-deficit/hyperactivity disorder in adults, revisited.

Authors:  Joseph Biederman; Stephen V Faraone; Michael C Monuteaux; Marie Bober; Elizabeth Cadogen
Journal:  Biol Psychiatry       Date:  2004-04-01       Impact factor: 13.382

10.  A review of the economic burden of ADHD.

Authors:  Louis S Matza; Clark Paramore; Manishi Prasad
Journal:  Cost Eff Resour Alloc       Date:  2005-06-09
View more
  2 in total

1.  Assessment of post-excitatory long-interval cortical inhibition in adult attention-deficit/hyperactivity disorder.

Authors:  Wolfgang Retz; Ernesto González-Trejo; Konstanze D Römer; Florence Philipp-Wiegmann; Philip Reinert; Yin Fen Low; Samir Boureghda; Michael Rösler; Daniel J Strauss
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-02-19       Impact factor: 5.270

2.  Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden - a longitudinal population-based register study.

Authors:  Maria Polyzoi; Ewa Ahnemark; Emma Medin; Ylva Ginsberg
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-07       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.